T-cell lymphoma is a type of non-Hodgkin lymphoma ... also run tests to identify specific genetic mutations or molecular markers to further characterize the lymphoma and guide treatment decisions.
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
6don MSN
Researchers and pediatric neurosurgeons at the University of Pittsburgh School of Medicine and UPMC Children's Hospital of ...
Our immune system works to fight infections immediately, but also maintain long-term immunity. Two waves of protection help ...
The data from the Phase 1/1b clinical trial of soquelitinib in patients with T cell lymphoma continues to demonstrate strong indications of anti-tumor activity in a significant number of patients,” ...
HOUSTON, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback